Home Markets US FDA rejects AbbVie’s wrinkle treatment due to manufacturing concerns US FDA rejects AbbVie’s wrinkle treatment due to manufacturing concerns Andrew M Apr 23, 2026 comments off Tweet on Twitter Share on Facebook Google+ Pinterest Original source: https://www.investing.com/news/stock-market-news/us-fda-rejects-abbvies-wrinkle-treatment-due-to-manufacturing-concerns-4634072 FDA manufacturing Market Updates www.investing.com/news/stock-market-news/us-fda-rejects-abbvies-wrinkle-treatment-due-to-manufacturing-concerns-4634072